Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(8 sites)

China

Chongqing University cancer hospital, Chongqing, Chongqing Municipality

Cancer Hospital of Shantou University Medical College, Shantou, Guangdong

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

LiaoNing Cancer Hospital & Institute, Shenyang, Liaoning

Shandong Provincial Hospital, Jinan, Shandong

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality

China West Hospital, Chengdu, Sichuan

GuiZhou Provincial People's Hospital, Guiyang